Japan PMDA's investigation results for five products

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1686卷 / 1期

关键词：

D O I：

10.1007/s40278-018-41069-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[41] PMDA's Challenge to Accelerate Clinical Development and Review of New Drugs in Japan
Ichimaru, K.
Toyoshima, S.
Uyama, Y.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (04) : 454 - 457
[42] PMDA revises precautions for three drugs in Japan
Reactions Weekly, 2021, 1879 (1) : 4 - 4
[43] Historical Overview of Regulatory Approvals and PMDA Assessments for Biosimilar Products in Japan During 2009-2022
Kuribayashi, Ryosuke
Nakano, Ayuki
Hariu, Aya
Kishioka, Yasuhiro
Honda, Futaba
BIODRUGS, 2023, 37 (04) : 443 - 451
[44] PMDA recommends revised precautions for various products
Reactions Weekly, 2015, 1577 (1) : 5 - 5
[45] Recent results on the spectroscopic investigation of PMDA/ODA-based polyimide model compounds
Schulze, T
Saini, AK
Patterson, HH
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 419 - POLY
[46] PMDA: labelling updates proposed for several products
Reactions Weekly, 2016, 1600 (1) : 5 - 6
[47] PMDA revises precautions and package inserts for five therapeutics
Reactions Weekly, 2021, 1836 (1) : 9 - 9
[48] Japan PMDA updates oxaliplatin label following fatality
Reactions Weekly, 2012, 1427 (1) : 3 - 3
[49] Meeting Report: PMDA Public Workshop on Pharmacometrics at Japan
Kijima, Shinichi
Ochiai, Yoshinori
Ishiguro, Akihiro
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (10): : 550 - 552
[50] Japan's wood products market
Wood Markets Newsl., 2006, 4 (4-5):

← 1 2 3 4 5 →